Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Announces Expanded Clinical Development Plan For Its Lead Cancer Vaccine VB10.16

Dec 20 (Reuters) - Nykode Therapeutics ASA  NYKD.OL :
    * NYKODE ANNOUNCES EXPANDED CLINICAL DEVELOPMENT PLAN FOR
ITS LEAD
CANCER VACCINE VB10.16 IN HPV16-POSITIVE CANCERS
    * NYKODE THERAPEUTICS ASA - DOSE-FINDING PHASE 1/2A TRIAL IN
1ST
LINE PATIENTS WITH ADVANCED HEAD AND NECK SQUAMOUS CELL
CARCINOMA TO BEGIN IN 1H2023

Source text for Eikon:  ID:nGNXbFM9Yy 
Further company coverage:  NYKD.OL 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Nykode Therapeutics ASA

See all news